Cargando…
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
BACKGROUND: Despite recent advances in research, there are still critical lacunae in our basic understanding of the cause, pathogenesis, and natural history of many cancers, especially heterogeneity in patient response to drugs and mediators in the transition from malignant to invasive phenotypes. T...
Autores principales: | Chitrangi, Swati, Vaity, Pooja, Jamdar, Aishwarya, Bhatt, Shweta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362580/ https://www.ncbi.nlm.nih.gov/pubmed/37479967 http://dx.doi.org/10.1186/s12885-023-11078-9 |
Ejemplares similares
-
Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023) -
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
por: Liu, Lisa, et al.
Publicado: (2021) -
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
por: Guillen, Katrin P., et al.
Publicado: (2022) -
Patient-Derived Cancer Organoids for Precision Oncology Treatment
por: Pernik, Mark N., et al.
Publicado: (2021) -
Facilitating shared decision-making in oncology
por: Sobrero, Alberto, et al.
Publicado: (2023)